RE:ps: When the damn breaks open with Epidiolex generic news, Absolutely!..partnership, not supply agreement..very smart move by global pharma partner....as previously mentioned generics always get covered by insurers before brand name..FDA /Launch approval will surely propel share price to levels not seen in years...vast majority of LABS shareholders are retail and we will not approve all equity M&A near our current valuation..management must understand this hopefully they do.